Combinations for the treatment of cancer comprising anti-EGFR antibody and VEGFR inhibitors

Details for Australian Patent Application No. 2006226897 (hide)

Owner Amgen Inc.

Inventors Chang, David

Agent Shelston IP

Pub. Number AU-B-2006226897

PCT Pub. Number WO2006/102504

Priority 60/664,381 22.03.05 US; none 21.03.06 US

Filing date 22 March 2006

Wipo publication date 28 September 2006

Acceptance publication date 7 May 2009

International Classifications

A61K 31/444 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

20 September 2007 PCT application entered the National Phase

  PCT publication WO2006/102504 Priority application(s): WO2006/102504

7 May 2009 Application Accepted

  Published as AU-B-2006226897

3 September 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006226901-Methods and systems for deriving seed position of a subscriber station in support of unassisted GPS-type position determination in a wireless communication system

2006226891-Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy